The Department of Health (DOH), the Philippine Thyroid Association (PTA), and Merck Inc. signed a Memorandum of Understanding (MOU) to join forces and raise awareness of thyroid diseases.
The MOU provides a framework for all parties to inform the public of thyroid diseases through advocacy, lay fora and improve the capability of professionals to diagnose and manage thyroid diseases. Also, local evidence-based clinical practice guidelines for the diagnosis and treatment for thyroid disorders will be developed and disseminated to physicians in the specialty societies, and primary care facilities.
Thyroid is a butterfly-shaped gland in the neck, just above the collarbone. Thyroid hormones control the body’s metabolism. These include how fast you burn calories and how fast your heart beats.
Thyroid diseases include goiter, hyperthyroidism, hypothyroidism, thyroid cancer and thyroid nodules. These are highly prevalent, yet neglected diseases in the Philippines. Data from the 2012 Philippine Thyroid Diseases Study (PhilTiDeS) revealed that almost 1 out of 10 Filipinos is affected by goiter. Thyroid function abnormalities affect around 8 percent of the population, with an estimated 3 percent affected by some form of hypothyroidism, and about 6 percent affected by some form of hyperthyroidism. These thyroid diseases affect women disproportionately, with women affected three times as much as men.
The Philippine Thyroid Association is a globally recognized association of professionals dedicated to the study and practice of Thyroidology and its dissemination for the welfare of the public.
Merck Inc. was founded in 1668 and is the world’s oldest pharmaceutical and chemical company. It has been in the Philippines since 1973, and provides quality laboratory, chemical, and pharmaceutical products and services to its customers.
– DOH Philippines